Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OBI-1 in Acquired Hemophilia A with Factor VIII Inhibitory Auto-antibodies
2011-000181-34Phase 2Completed
- Sponsor
- Baxter International Inc.
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of susoctocog alfa in acquired haemophilia (AH), sponsored by Baxter International Inc. Primary endpoint: Primary efficacy endpoint. Started Jun 2011; status: completed.
02
Drugs
susoctocog alfa
03
Conditions
acquired haemophilia (AH)
Beyond the preview
Go deeper on 2011-000181-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000181-34.